Access to Medicine Versus Test Data Exclusivity Safeguarding Flexibilities Under International Law /
| Main Author: | |
|---|---|
| Corporate Author: | |
| Summary: | XVI, 256 p. 78 illus., 56 illus. in color. text | 
| Language: | English | 
| Published: | Berlin, Heidelberg :
          Springer Berlin Heidelberg : Imprint: Springer,
    
        2016. | 
| Edition: | 1st ed. 2016. | 
| Series: | Munich Studies on Innovation and Competition,
              4 | 
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-662-49655-8 | 
| Format: | Electronic Book | 
                Table of Contents: 
            
                  - Introduction
- Test Data Exclusivity: Raison d'être
- Test Data Exclusivity and Art 39(3) TRIPS
- Test Data Exclusivity in the US and the EU
- Index of Data Exclusivity and Access (IDEAS) - Free Trade Agreements
- Index of Data Exclusivity and Access (IDEAS) - National Laws
- Test Data Exclusivity in FTAs and Access to Originator Pharmaceuticals
- Conclusions and Recommendations.